Assembly Biosciences, Inc. (ASMB) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 232.61M | 254.55M | 236.81M | 77.47M | 95.53M | 115.5M | 98.21M | 112.93M | 117.17M | 133.79M | 49.67M | 64.08M |
| Cash & Short-Term Investments | 226.6M | 248.11M | 232.56M | 74.98M | 91.03M | 112.08M | 94.95M | 109.22M | 112.98M | 130.25M | 46.21M | 59.83M |
| Cash Only | 31.12M | 58.45M | 22.53M | 24.01M | 23.41M | 38.34M | 28.45M | 19.21M | 18.75M | 19.84M | 26.66M | 21.62M |
| Short-Term Investments | 195.48M | 189.66M | 210.02M | 50.97M | 67.61M | 73.73M | 66.5M | 90.01M | 94.23M | 110.41M | 19.55M | 38.21M |
| Accounts Receivable | 451K | 974K | 912K | 0 | 0 | 400K | 0 | 0 | 43K | 43K | 0 | 342K |
| Days Sales Outstanding | 7.81 | 2.04 | 7.78 | - | - | 5 | - | - | 0.68 | 0.55 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.56M | 5.47M | 0 | 300K | 4.5M | 3.02M | 3.26M | 3.71M | 4.15M | 3.5M | 100K | 100K |
| Total Non-Current Assets | 2.9M | 3.04M | 3.19M | 3.31M | 3.49M | 3.67M | 2.05M | 2.39M | 2.71M | 3.68M | 1.96M | 2.5M |
| Property, Plant & Equipment | 2.58M | 2.73M | 2.87M | 3M | 3.18M | 3.35M | 1.74M | 2.08M | 2.4M | 2.72M | 1.41M | 2.16M |
| Fixed Asset Turnover | 3.09x | 15.16x | 3.67x | 3.12x | 2.88x | 2.89x | 3.59x | 3.81x | 2.26x | 3.47x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 312K | 312K | 312K | 312K | 312K | 312K | 312K | 312K | 312K | 312K | 552K | 332K |
| Total Assets | 235.51M | 257.59M | 240M | 80.78M | 99.02M | 119.17M | 100.26M | 115.32M | 119.88M | 137.47M | 51.63M | 66.58M |
| Asset Turnover | 0.03x | 0.17x | 0.07x | 0.11x | 0.09x | 0.07x | 0.06x | 0.07x | 0.04x | 0.08x | - | - |
| Asset Growth % | 137.85% | 116.16% | 139.37% | -29.95% | -17.41% | -13.31% | 94.2% | 73.22% | 44.24% | 35.05% | -57.51% | -53.59% |
| Total Current Liabilities | 35M | 48.78M | 53.38M | 47.29M | 46.63M | 47.8M | 41.63M | 41.27M | 38.75M | 39.23M | 7.13M | 8.83M |
| Accounts Payable | 1.13M | 1.17M | 1.68M | 743K | 875K | 585K | 1.33M | 801K | 727K | 461K | 758K | 904K |
| Days Payables Outstanding | 3.98K | 4.1K | - | 4.57 | - | 6.18 | - | 2.17K | 1.69K | 667.55 | 7.06 | 7.73 |
| Short-Term Debt | 590K | 569K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 29.08M | 36.9M | 0 | 0 | 40.82M | 37.62M | 32.62M | 33.06M | 32.77M | 30.91M | 0 | 0 |
| Other Current Liabilities | 4.2M | 10.14M | 42.36M | 40.92M | 1.82M | 6.48M | 6.35M | 2.79M | 1.73M | 1.15M | 0 | 99K |
| Current Ratio | 6.65x | 5.22x | 4.44x | 1.64x | 2.05x | 2.42x | 2.36x | 2.74x | 3.02x | 3.41x | 6.96x | 7.26x |
| Quick Ratio | 6.65x | 5.22x | 4.44x | 1.64x | 2.05x | 2.42x | 2.36x | 2.74x | 3.02x | 3.41x | 6.96x | 7.26x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.9M | 2.06M | 3.92M | 15.39M | 25.25M | 38.01M | 32.62M | 39.37M | 48.53M | 57.15M | 2.78M | 2.8M |
| Long-Term Debt | 1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 2.06M | 2.21M | 2.35M | 2.49M | 2.63M | 113K | 451K | 791K | 1.12M | 50K | 64K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 646K | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 1.72M | 13.04M | 0 | 0 | 0 | 0 | 0 | 0 | 2.73M | 2.73M |
| Total Liabilities | 36.9M | 50.84M | 57.3M | 62.68M | 71.88M | 85.81M | 74.26M | 80.64M | 87.28M | 96.37M | 9.91M | 11.63M |
| Total Debt | 2.49M | 2.63M | 2.75M | 2.88M | 3.02M | 3.09M | 1.44M | 1.75M | 1.94M | 2.34M | 919K | 1.77M |
| Net Debt | -28.63M | -55.82M | -19.78M | -21.12M | -20.39M | -35.26M | -27.01M | -17.46M | -16.81M | -17.5M | -25.74M | -19.86M |
| Debt / Equity | 0.01x | 0.01x | 0.02x | 0.16x | 0.11x | 0.09x | 0.06x | 0.05x | 0.06x | 0.06x | 0.02x | 0.03x |
| Debt / EBITDA | - | 0.13x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | -2.81x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 198.61M | 206.75M | 182.69M | 18.1M | 27.13M | 33.36M | 26M | 34.68M | 32.6M | 41.1M | 41.71M | 54.95M |
| Equity Growth % | 631.99% | 519.78% | 602.59% | -47.81% | -16.77% | -18.83% | -37.66% | -36.88% | -53.65% | -50.28% | -59.27% | -55.68% |
| Book Value per Share | 11.75 | 18.44 | 23.86 | 2.36 | 3.61 | 5.07 | 4.09 | 6.15 | 5.95 | 7.50 | 9.52 | 12.62 |
| Total Shareholders' Equity | 198.61M | 206.75M | 182.69M | 18.1M | 27.13M | 33.36M | 26M | 34.68M | 32.6M | 41.1M | 41.71M | 54.95M |
| Common Stock | 16K | 16K | 16K | 8K | 8K | 7K | 6K | 6K | 5K | 5K | 53K | 52K |
| Retained Earnings | -841.13M | -832.05M | -854.14M | -844.94M | -834.74M | -825.92M | -815.59M | -805.98M | -794.83M | -785.75M | -774.79M | -760.37M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -368K | -41K | -90K | -279K | -253K | -211K | -156K | -293K | -239K | -81K | -275K | -325K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |